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Objective: The objective of this study was to review our 27-year clinical experience with open proximal abdominal aortic
aneurysm repairs, with a focus on long-term survival.
Methods: A retrospective cohort study was undertaken of all patients who underwent proximal abdominal aortic aneurysm
repair between 1986 and 2013 at a tertiary care referral center. Demographics, operative variables, complications, and 30-
day mortality were analyzed. Postoperative acute kidney injury was analyzed by the RIFLE (Risk, Injury, Failure, Loss,
End-stage renal disease)/Acute Kidney Injury Network criteria. Long-term survival was assessed through review of
electronic medical records and the Social Security Death Index. Associations between demographics and complications
were investigated to determine predictors of long-term survival.
Results: The study identiﬁed 245 patients. Mean age was 71 years (range, 38-92 years); 69% were men, and 88% were
white. Aneurysm type was juxtarenal in 127 patients (52%), suprarenal in 68 patients (28%), and type IV thor-
acoabdominal in 50 patients (20%). In-hospital mortality was 3.3% (eight patients), and 30-day mortality was 2.9% (seven
patients). At least one major complication occurred in 64% of the patients, which included the following: acute kidney
injury, 60% (persistent acute kidney injury at discharge, however, was 28%, and hemodialysis at discharge was 1.6%);
major pulmonary complications, 22%; myocardial infarction, 4%; visceral ischemia, 2%; and paraplegia, 0.5%. Median
follow-up was 54 months. Kaplan-Meier survival estimates were 70% at 5 years and 43% at 10 years. Variables associated
with poorer survival included congestive heart failure (hazard ratio [HR], 3.5; P < .001), chronic obstructive pulmonary
disease (HR, 1.8; P < .002), and increased aneurysm size at presentation (HR, 1.1; P < .013). Persistent stage 3 acute
kidney injury was associated with poor long-term survival.
Conclusions: Open surgical repair of proximal abdominal aortic aneurysms can be performed with low mortality. Acute
kidney injury is the most frequent complication, but the need for hemodialysis at discharge is low. Long-term survival is
favorable. These data should assist in establishing benchmarks for endovascular repair of complex proximal abdominal
aortic aneurysms. (J Vasc Surg 2014;59:1488-94.)Proximal abdominal aortic aneurysms (P-AAAs) ac-
count for 8% to 20% of abdominal aortic aneurysms
(AAAs). These P-AAAs include juxtarenal AAAs (JR-
AAAs), suprarenal AAAs (SR-AAAs), and, in some series,
type IV thoracoabdominal aneurysms (TAAAs).1,2 Open
repair of P-AAAs is associated with greater morbidity and
mortality rates compared with repair of infrarenal AAA
(IR-AAA).3,4 Mortality after P-AAAs repair is reported to
bebetween3% and8%, comparedwith1% to 5% after elective
IR-AAA repair in high-volume tertiary referral centers.3
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8studied extensively, less is known about the long-term sur-
vival. Furthermore, fenestrated and branched aortic endo-
grafts have recently been developed and are now being
used in selected patients with P-AAAs.5 Long-term out-
comes of fenestrated and branched endograft repairs remain
uncertain. We reviewed our experience with P-AAAs to
determine factors associated with perioperative morbidity,
mortality, and long-term patient survival.
METHODS
Between January 1986 and February 2013, 1536 pa-
tients underwent AAA repair at our tertiary care referral
center. Of those, 245 patients (16%) were treated for
P-AAAs and form the subject of this report. All ruptured
or occluded aneurysms, IR-AAAs, and type I to type III
TAAAs were excluded. Data were collected retrospectively
by electronic and manual chart reviews. The primary
outcome measures analyzed were in-hospital and 30-day
mortality. Long-term survival was assessed through review
of electronic medical records and the Social Security Death
Index. Complications were reported according to estab-
lished guidelines.6 Assignment of aneurysm extent was
based on preoperative radiographic imaging or operative
ﬁndings. Complex AAAs were classiﬁed by the recommen-
ded reporting standard for aortic aneurysm repair of the
Society for Vascular Surgery.7 JR-AAAs were deﬁned as
Table I. Cox survival analysis variables associated with
long-term mortality
Parameter HR 95% CI P value
Age 1.0 0.96-1.00 .062
Male 0.8 0.54-1.06 .102
Aneurysm type 1.1 0.72-1.56 .780
Coronary artery disease 1.3 0.91-1.80 .149
Smoking 1.6 0.81-3.18 .173
Chronic obstructive
pulmonary disease
1.8 1.26-2.56 .001a
Congestive heart failure 4 2.05-7.68 <.001a
Diabetes mellitus 0.8 0.44-1.26 .277
History of stroke 1.9 1.02-3.54 .040a
Hyperlipidemia 0.6 0.40-0.90 .015a
Preoperative CKD 0.5 0.16-1.63 .256
Aneurysm size 1.1 1.02-1.22 .012a
Date of surgery (2000-2013) 0.9 0.54-1.41 .575
Persistent AKI at discharge 1.2 0.87-1.76 .245
Stage 1 AKI at discharge 0.9 0.59-1.37 .631
Stage 2 AKI at discharge 1.6 0.69-3.65 .272
Stage 3 AKI at discharge 2.9 1.40-5.98 .004a
Postoperative myocardial infarction 1.9 0.69-5.08 .221
Vent dependence > 72 hours 1.0 0.62-1.61 1.0
Postoperative pneumonia 1.3 0.77-2.25 .320
Postoperative bowel ischemia 2.6 1.15-6.00 .022a
AKI, Acute kidney injury; CI, conﬁdence interval; CKD, chronic kidney
disease; HR, hazard ratio.
aSigniﬁcant at P < .05.
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no infrarenal aortic segment suitable for clamping. SR-AAAs
involved the oriﬁce of at least one renal artery but did not
include the origins of the visceral vessels. Type IV TAAAs
involved the visceral vessels but did not extend above the
diaphragm. Aortic clamp position was designated suprare-
nal, above the superior mesenteric artery but below the ce-
liac artery, or supraceliac.
Preoperative, operative, and postoperative vari-
ables. Coronary artery disease was deﬁned as a positive car-
diac stress test result, history of myocardial infarction, and
history of percutaneous coronary intervention or coronary
artery bypass grafting. Congestive heart failure was identi-
ﬁed by a cardiologist’s report or an ejection fraction of
less than 30% by objective testing. Preoperative hyperten-
sion, diabetes, and hyperlipidemia were identiﬁed by
patients’ medications or dietary instructions. Chronic
obstructive pulmonary disease was identiﬁed by medical
history or by review of treatment requiring inhalers. Esti-
mated glomerular ﬁltration rate (eGFR) was measured by
the simpliﬁed Modiﬁcation of Diet in Renal Disease for-
mula, which provides an eGFR relative to serum creatinine
(SCr) concentration based on age, race, and sex.8 Baseline
SCr levels were assigned by use of the nearest preoperative
value to the date of operation. Preoperative chronic kidney
disease (CKD) was considered present if the preoperative
eGFR was less than 60 mL/min/1.73 m2. Moderate renal
dysfunction (CKD stage 3) was deﬁned as eGFR between
30 and 60 mL/min/1.73 m2. Severe renal dysfunction
(CKD stage 4) was deﬁned as eGFR between 15 and
30 mL/min/1.73 m2, and end-stage renal disease (CKD
stage 5) was designated if the eGFR was <15 mL/min/
1.73 m2, even if the patient was not on dialysis.
In general, these operations were undertaken by a staff
surgeon with a vascular surgery fellow or chief surgical resi-
dent. It is recognized that a devoted anesthetic team that
has had experience with these types of operations is instru-
mental to a favorable patient outcome.
Operative approaches were midline transperitoneal, left
ﬂank retroperitoneal, and thoracoabdominal. Cold renal
perfusion with an isotonic heparinized balanced salt solu-
tion (containing 1000 units heparin sodium, 25 g mannitol,
22 mEq sodium bicarbonate, and 500 mg methylpredniso-
lone per liter) was used at the surgeon’s discretion.
Both 30-day and in-hospital mortality were docu-
mented. Morbidity included major cardiac, pulmonary,
neurologic, mesenteric, and renal complications. Myocar-
dial infarction was diagnosed by biochemical markers or
evidence of cardiac injury on electrocardiography. Pulmo-
nary failure was deﬁned as ventilator dependence for
more than 72 hours, need for reintubation, development
of pneumonia, or need for tracheostomy. Postoperative
renal dysfunction or acute kidney injury (AKI) was catego-
rized by the new RIFLE (Risk, Injury, Failure, Loss, End-
stage renal disease)/Acute Kidney Injury Network (AKIN)
grading scheme recently described.8 This classiﬁcation
scheme has three grades based on changes in SCr concen-
tration (or GFR) or urine output, in which even smallchanges in SCr concentration (>0.3 mg/dL) can lead to
a diagnosis of AKI. Stage 1 AKI (risk) was considered pre-
sent if there was a rise in SCr concentration by 0.3 mg/dL
or an increase 1.5 to 1.9 times the baseline value. Stage 2
(injury) was deﬁned as an increase in SCr concentration
2.0 to 2.9 times the baseline value. Stage 3 (failure) was
deﬁned as an increase in SCr concentration 3.0 times the
baseline value, increase in SCr concentration to
>4.0 mg/dL, or initiation of renal replacement therapy.
Patients were considered to have recovered their renal
function (transient AKI) if their SCr concentration
returned to within 0.3 mg/dL of their baseline SCr con-
centration at the time of discharge. If the SCr concentra-
tion remained more than 0.3 mg/dL above the baseline
value at discharge, the patient was classiﬁed as having
persistent AKI. We used the same classiﬁcation of AKI at
discharge to determine the severity of persistent AKI.
The need for temporary or permanent dialysis was
recorded.
Data analysis. All patient data were compiled in a
spreadsheet (Excel; Microsoft Corp, Redmond, Wash). Pro-
portions were compared with the Pearson c2 tests, Fisher
exact tests, and logistic regression. Means were compared
by t-tests and analysis of variance. Analyses were carried out
with SAS 9.3 (SAS Institute, Cary, NC). A P value < .05
was considered statistically signiﬁcant. For survival data,
Kaplan-Meier estimates were computed, and Cox propor-
tional hazards regression was used to test for associations
between survival and variables of interest (Table I). All of the
long-term survival analyses were calculated from the date of
the operation.
Table II. Baseline characteristics of patients undergoing
open proximal abdominal aortic aneurysm (P-AAA) repair
Characteristic No.
No. (%) or
mean (SD), range
Age, years 245 71.0 (7.9), 38-92
Male 245 169 (68.8)
White 245 217 (88)
Aneurysm size, cm 241 6.4 (1.9), 3.1-14
Degenerative 220 203 (92)
Coronary artery disease 245 103 (42)
Chronic obstructive pulmonary disease 224 81 (36)
Hypertension 243 204 (84)
Smoking 229 193 (85)
Diabetes 243 33 (14)
Cerebrovascular disease 232 24 (10)
Hyperlipidemia 208 105 (50)
Preoperative eGFR, mL/min/1.73 m2 241 62 (21), 14-166
Preoperative creatinine level, mg/dL 241 1.2 (0.4), 0.5-4.1
CKD 245 134 (55)
CKD, Chronic kidney disease; eGFR, estimated glomerular ﬁltration rate;
SD, standard deviation.
Table III. Operative details of patients undergoing
proximal abdominal aortic aneurysm (P-AAA) repair
No. (%) or
mean (SD), range
Approach (n ¼ 245)
Transabdominal 54 (22)
Retroperitoneal 118 (48)
Thoracoabdominal 73 (30)
Proximal clamp location (n ¼ 243)
Suprarenal 93 (38)
Supramesenteric (but below celiac) 8 (3)
Supraceliac 142 (58)
Operative time, minutes (n ¼ 114) 428 (132), 230-946
Clamp time, minutes (n ¼ 205) 36 (16), 5-100
Type of graft (n ¼ 242)
Tube 154 (64)
Bifurcated 88 (36)
Intraoperative ﬂuids (n ¼ 160)
Estimated blood loss, liters 2.9 (2.4), 0.5-24
Cell Saver blood, units 5.5 (4.6), 0-23
Blood transfusion, units 2.6 (2.6), 0-15
SD, Standard deviation.
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Demographics. Baseline characteristics are summa-
rized in Table II. There were 127 patients with JR-AAAs
(52%), 68 patients with SR-AAAs (28%), and 50 patients
with type IV TAAAs (20%). Stage 3 CKD was noted in 122
(50%) of our patients; stage 4 was present in seven patients
(3%), and stage 5 was present in ﬁve patients (2%). There
were four patients (1.6%) on hemodialysis (HD) preoper-
atively. Degenerative aneurysms composed 92% of the
cohort; nine patients (4%) had an inﬂammatory aneurysm,
seven patients (3%) had a juxta-anastomotic aneurysm
above a previous IR-AAA repair, and one patient had an
infected aneurysm. The anastomotic aneurysms included
two JR-AAAs, three SR-AAAs, and two type IV TAAAs.
Operative management. Table III summarizes the
operative details. Our usual approach to P-AAA repair was
through a left ﬂank retroperitoneal or thoracoabdominal inci-
sion (78%); a left ﬂank approach was used in 71% and 75% of
JR-AAAs and SR-AAAs, respectively. Proximal aortic control
was achieved with supraceliac clamping in 58% of the patients,
with39%of JR-AAAs repairedwithsupraceliac control. Sixteen
patients (13%) with JR-AAAs had a clamp placed between
the renal arteries. Cold renal perfusion was used in 16% of
JR-AAAs, 61% of SR-AAAs, and 88% of type IV TAAAs.
Renal dysfunction. On the basis of the new, sensitive
RIFLE/AKIN classiﬁcation scheme, 60% of our patients
had transient AKI (Table IV). This incidence increased
with the proximal extension of the aneurysm, affecting 47%
of JR-AAA, 68% of SR-AAA, and 80% of type IV TAAA
patients. AKI was stage 1 in 58% of the patients. There was
resolution of the AKI in 54% of the patients by the time of
discharge; 28% of the patients were discharged with
persistent AKI (18%, 37%, and 44% for JR-AAAs, SR-AAAs,
and type IV TAAAs, respectively). At discharge, 17 patients
(7%) had AKI stage 2 or stage 3. Ten patients (4%) needed
HD during their hospitalization, whereas four patients(1.6%) were discharged on HD. We did not ﬁnd that pre-
operative CKD had a statistically adverse effect on post-
operative renal function (51% vs 56%; P ¼ .4).
SCr levelswereobtained in161patientsduringan average
follow-up period of 64 months (range, 3-227 months). Of
these patients, 44 had persistent AKI at discharge. Of the 44
patients with persistent AKI at discharge, 12 (27.3%) had an
improvement in their SCr level by >0.5 mg/dL, 10
(22.7%) had a worsening of their SCr level by >0.5 mg/dL,
and 22 (50.0%) had the same SCr level (60.5 mg/dL).
Four patients who were discharged with persistent AKI (9%)
progressed to HD. There were 117 patients with long-term
SCr concentration follow-up who were discharged without
AKI. Thirty-one (26.5%) of these patients had a worsening
of their SCr level by>0.5mg/dL. Four patients in this group
progressed to HD (3.4%). The proportion of patients who
had worsening SCr concentration was not signiﬁcantly
different between the two groups (P ¼ .6248).
Morbidity and mortality. Among the 245 patients,
157 patients (64%) experienced at least one complication
(Table V). If we included only persistent AKI at
discharge and not any postoperative AKI as a complication,
our complication results would be 45% for the total cohort,
with 30%, 53%, and 76% for JR-AAAs, SR-AAAs, and type
IV TAAAs, respectively.
The second most common complication was pulmo-
nary, occurring in 55 patients (22%), with rates of 15%,
26%, and 36% for JR-AAAs, SR-AAAs, and type IV TAAAs,
respectively. Neurologic complications occurred in seven
patients (3%) (4 strokes, 2 states of confusion and weakness
without a deﬁnite etiology, and 1 paraplegia in a type IV
TAAA patient).
Despite similar preoperative demographics and comor-
bidities, the risk of complications increased with the prox-
imal extension of the aneurysm (Table VI). When clamp
positions in JR-AAAs and SR-AAAs were assessed by
Table IV. Renal outcomes of patients undergoing proximal abdominal aortic aneurysm (P-AAA) repair
Characteristics
All patients (N ¼ 245),
No. (%)
JR-AAA (n ¼ 127),
No. (%)
SR-AAA (n ¼ 68),
No. (%)
TAAA-4 (n ¼ 50),
No. (%)
Postoperative AKI 144 (60) 59 (47) 45 (68) 40 (80)
Number of patients at discharge (N ¼ 234) (n ¼ 121) (n ¼ 65) (n ¼ 48)
Persistent AKI at discharge 67 (28) 22 (18) 23 (35) 21 (44)
AKI stage at discharge
Stage 1 50 (21) 14 (12) 20 (30) 16 (33)
Stage 2 9 (4) 3 (2) 2 (3) 4 (8)
Stage 3 8 (3) 5 (4) 2 (3) 1 (2)
Need HD postoperatively 10 (4) 4 (3) 4 (6) 2 (4)
Discharged on HD 4 (1.6) 2 (1.5) 1 (1.5) 1 (2)
AKI, Acute kidney injury; HD, hemodialysis; JR-AAA, juxtarenal abdominal aortic aneurysm; SR-AAA, suprarenal abdominal aortic aneurysm; TAAA-4,
type IV thoracoabdominal aneurysm.
Table V. Clinical outcomes of patients undergoing
proximal abdominal aortic aneurysm (P-AAA) repair
Characteristics (N ¼ 245), No. (%)
In-hospital mortality 7 (2.9)
30-day mortality 8 (3.3)
Median hospital stay (IQR), days 9 (7-14)
Postoperative complications No. (%)
Any postoperative AKI 144 (60)
Pulmonary 55 (22)
Myocardial infarction 9 (4)
Return to surgery for postoperative bleeding 7 (3)
Neurologic complications 7 (3)
Paraplegia 1 (1)
Bowel ischemia requiring resection 5 (2)
AKI, Acute kidney injury; IQR, interquartile range.
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found no difference in mortality or major complications be-
tween the two groups.
Thirty-day mortality was 3.3% (eight patients); in-
hospital mortality was 2.9% (seven patients). Four patients
(3%) with JR-AAAs died, 2 of progressive multiorgan fail-
ure 10 and 15 days after the operation, 1 of coagulopathy
on the second postoperative day after supraceliac clamping,
and 1 of an intraoperative cardiac event at the end of the
procedure. One patient (1%) with SR-AAA repaired with
supraceliac aortic clamping died on the second postopera-
tive day of multiorgan failure secondary to bowel ischemia.
Two patients (4%) with type IV TAAAs died: one devel-
oped delayed paraplegia on postoperative day 14 along
with respiratory failure and renal failure; the other died
on postoperative day 28 of progressive multiorgan failure.
One patient with JR-AAA who had an uneventful postop-
erative course and was discharged on postoperative day 8
died suddenly at home; the cause of death was unknown.
AKI was associated with in-hospital mortality; 5% of the pa-
tients who developed AKI died, whereas none (0%) of the
patients who did not develop AKI died (P ¼ .018).
Predictors of long-term survival. Kaplan-Meier sur-
vival estimates at 12, 60, and 120 months were 87.8%,70.4%, and 42.6%, respectively (Fig). Cox proportional
hazards regression was used to test for associations between
survival and variables of interest (Table I). No signiﬁcant
association was found with age, sex, history of coronary
disease, or preoperative CKD (at any stage). A history of
chronic obstructive pulmonary disease (hazard ratio [HR],
1.8; 95% conﬁdence interval [CI], 1.23-2.49), congestive
heart failure (HR, 3.5; 95% CI, 1.81-6.79), and history of
stroke (HR, 1.9; 05% CI, 1.03-3.58) were associated with
worse survival. Preoperative hyperlipidemia was associated
with improved survival. Aneurysm size at presentation
(HR, 1.1; 95% CI, 1.02-1.21) was associated with worse
survival, but the proximal extent of the aneurysm (JR-AAA
vs SR-AAA vs type IV TAAA) was not. Development of
postoperative AKI did not have statistically signiﬁcant
association with long-term survival. However, persistent
stage 3 AKI at discharge was associated with worse long-
term survival (HR, 2.9; 95% CI, 1.40-5.98).
DISCUSSION
A number of centers have reported their outcomes
with such repair.3,4,9 In 1986, Crawford et al10 were the
ﬁrst to report a series of JR-AAA repairs, with a mortality
of 7.9% and a dialysis-dependent renal failure rate of 8%.
The largest series in the literature to date was from Jean-
Claude et al4 with 257 patients. Of those, 180 had JR-
AAAs and SR-AAAs. Overall mortality was 5.8%. Sarac
et al9 published their experience covering 138 JR-AAA pa-
tients, with 27% undergoing concomitant renal artery
reconstruction. Mortality was 5.1%, and postoperative
AKI occurred in 28%. West et al3 reported their data on
P-AAA repairs during a decade. In their review, mortality
was 2.5%, and the incidence of postoperative AKI was
22%. The 5-year survival rate was 64% in a subset of pa-
tients with JR-AAAs.11 Nathan et al12 reported their results
of open type IV TAAA repair. They had a 5.6% mortality,
long-term HD was required in 6.1%, and their 5-year sur-
vival was 50%. Gupta et al13 examined data from the Na-
tional Surgical Quality Improvement Program and
identiﬁed 598 patients who had undergone repair of P-
AAAs between 2007 and 2009. They noted that peripheral
vascular disease, chronic obstructive pulmonary disease,
Table VI. Comparison between the different types of aneurysm repairs
Group No. JR No. SR No. Type IV P value
Age, years, mean (SD) 127 70.7 (7.7) 68 69.5 (7.4) 50 68.2 (9.1) .1680
Male, No. (%) 127 91 (72) 68 42 (62) 50 36 (72) .3179
Aneurysm size, cm, mean (SD) 125 6.6 (1.9) 68 6.3 (1.4) 48 6.3 (1.6) .3888
Preoperative CKD, No. (%) 127 71 (56) 68 39 (58) 50 24 (48) .5562
Coronary artery disease, No. (%) 127 53 (42) 68 30 (44) 50 21 (42) .9473
Chronic obstructive pulmonary disease, No. (%) 114 42 (37) 64 24 (38) 46 15 (33) .8504
Complications, No. (%) 127 38 (30) 68 36 (53) 50 37 (74) <.0001
AKI at discharge, No. (%) 121 22 (18) 65 24 (37) 48 21 (44) .0012
AKI, Acute kidney injury; CKD, chronic kidney disease; JR, juxtarenal; SD, standard deviation; SR, suprarenal.
Categorical variables: c2 test of independence.
Numeric variables: analysis of variance.
Fig. Kaplan-Meier survival estimates at 12, 60, and 120 months were 87.8%, 70.4%, and 42.6%, respectively.
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mortality. Two meta-analyses looking at P-AAA repair re-
sults were published. Tallarita et al14 analyzed 30 articles,
covering P-AAA repairs in 2228 patients. Mean mortality
was 4.1% (0%-11%), and AKI occurred in an average of
31% (2%-40%), with permanent dialysis in 3% (0%-5%).
Jongkind et al15 analyzed 21 studies covering 1256 pa-
tients with JR-AAAs. The mean perioperative mortality
was 2.9%; AKI occurred in a mean of 18% of patients
(range, 0%-39%), with new-onset HD required in 3.3%.
These results may be difﬁcult to replicate outside large ter-
tiary centers because more than 60% of IR-AAAs are now
being repaired by endovascular techniques. This paradigm
shift in AAA repair decreases the open aortic experience for
vascular surgeons in training.16 We provided contemporary
results of JR-AAA, SR-AAA, and type IV TAAA repair.
Our overall mortality rate for the entire cohort was 2.9%:
3% for JR-AAAs, 1.5% for SR-AAAs, and 4% for type IVTAAAs. Even though we showed no difference in mortality
among the aneurysm types, there was an increase in
morbidity as the aneurysm moved more proximally (30%
vs 53% vs 74%). Our high rate of AKI is probably due to
the new Disease Outcomes Quality Initiative classiﬁcation.
This new scale may be extremely sensitive as the majority of
patients recovered renal function before discharge, with 7%
of patients being discharged with AKI stage 2 and stage 3
and 1.6% being discharged on HD.
Most patients in this series underwent a retroperitoneal
approach (78%); our group previously reported a favorable
experience with this approach.17 This exposure gives excel-
lent visualization of the left renal and visceral arteries and
allows unimpeded access to the proximal aorta for clamp-
ing at any level. In addition, the left renal vein is spared
injury or transection.
Because of reduced cardiac strain and avoidance of
visceral ischemia, distal clamping has always been favored
JOURNAL OF VASCULAR SURGERY
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immediately proximal to the renal arteries may prove to
be a problem because of the presence of atherosclerosis,
the poor quality of the aortic wall, and the risk of injury
to the superior mesenteric artery originating close to the
renal arteries.18,19 Supraceliac cross-clamping can circum-
vent some of these problems and has been advocated by
some as an acceptable method for proximal aortic control
in these aneurysms.19 Advantages of supraceliac cross-
clamping are that it is technically easier to perform, there
is reliably less atherosclerotic disease at this level, and the
clamp is placed at a site remote from the aortic disease,
allowing better exposure for the proximal anastomosis.
However, many studies have shown that supraceliac cross-
clamping in the elective setting is associated with increased
morbidity and mortality secondary to increased physiologic
stress, greater strain on the left ventricle, and obligatory
vital organ ischemia. These problems can be minimized by
experienced anesthetic management (afterload reduction
during aortic clamping, correction of acidosis, and avoid-
ance of declamping hypotension), reduction of cross-
clamp time, and selective cold perfusion of the renal and
visceral vessels. Shortell et al20 reported a series of 112
patients with JR-AAAs. Their mortality rate was 6%, and
their renal complications rate was 12%. The majority of their
patients underwent supraceliac cross-clamping, and they did
not ﬁnd a difference in outcome between supraceliac and
suprarenal clamping. However, other studies have identiﬁed
supraceliac clamping as a predictor of morbidity and mortal-
ity.3,4,9 In the current series, we did not ﬁnd clamp location
to be signiﬁcantly associated with in-hospital mortality or
major complications, including renal dysfunction. This
may be explained by our routine use of supraceliac clamp-
ing, which was employed in 58% of our cases.
Long-term renal insufﬁciency has not been addressed
very well in the literature. Tsai et al21 reported a 10% inci-
dence of late renal insufﬁciency. In our study, 26% of the
patients had worsening renal function over time.
Pulmonary complications have been attributed to
blood loss, length of surgery, and radial incision of the dia-
phragm.22 In this series, pulmonary complications were the
second most common cause of postoperative morbidity
(22%), and its incidence increased with proximal aneurysm
extension (15% for JR-AAAs, 25% for SR-AAAs, and 36%
for type IV TAAAs).
There are now abundant data in the literature support-
ing the notion that an acute increase in SCr concentration
of >0.3 mg/dL is independently associated with higher
mortality.8,23 The Clinical Practice Guideline for Acute
Kidney Injury8 proposed use of the term acute kidney
injury/impairment (AKI) to encompass the entire spec-
trum of renal dysfunction, from minor changes in markers
to requirement for renal replacement therapy. This guide-
line proposed use of the RIFLE/AKIN classiﬁcation as
was alluded to in the Methods section. In our study, the
incidence of preoperative CKD was 55%, higher than in
any other reported study (0%-52%).14 The new and
more restrictive standard we used to deﬁne CKD(eGFR < 60 mL/min/1.73 m2), however, undoubtedly
contributed to our higher than expected preoperative inci-
dence of CKD. AKI was the most common postoperative
complication in our series, developing in 60% of patients.
Persistent AKI at discharge occurred in 28% of patients.
These rates are higher than in previous reports, again because
of our use of the new, more stringent classiﬁcation system,8
which included an increase of SCr concentration of
0.3 mg/dL in the deﬁnition of AKI. The application of
this very sensitive criterion unmasked a 30% increase in post-
operative AKI (from 41% to 60%) and persistent AKI at
discharge (from 18% to 28%). However, only 7% of patients
were discharged with stage 2 or stage 3 AKI. Our discharge
HD rate was low at 1.6% and compared well with that found
in the literature (0%-5%).13 We found that development of
AKI postoperatively was a prognostic factor for in-hospital
mortality. This association has been conﬁrmed in other
studies.8,24 However, only persistent stage 3 AKI at
discharge was a prognostic factor in long-term mortality.
Our long-term survival rates at 5 and 10 years were
70% and 43%, respectively. This was similar to long-term
survival estimates for IR-AAA in other publications.25-28
We found that patients with hyperlipidemia (deﬁned as
patients taking statin therapy) had a better long-term survival.
The correlation of statin use with improved late survival is
consistent with data from other reports covering IR-AAA.29
We also found a relationship between aneurysm size at presen-
tation anddecreased long-term survival. Thisﬁndinghas been
reported before with IR-AAA.30 It is assumed that patients
with small AAAs tend to be better surgical candidates with
fewer comorbidities than patients with larger AAAs.31
Limitations. This study has a number of limitations.
Our analysis was retrospective. Variables analyzed were
limited to those recorded. In addition, there was bias in
selecting patients, with high-risk P-AAA patients not
offered surgery and not represented. Operative variables,
such as the operative approach used and the site of aortic
clamp placement, were surgeon dependent.
CONCLUSIONS
P-AAA repair can be accomplished with acceptable
morbidity and low mortality. The most common complica-
tion remains AKI, most of which resolved, with only few
patients developing clinically signiﬁcant AKI at discharge.
In our hands, long-term survival after P-AAA repair is com-
parable to that after IR-AAA repair.
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